Adegoke Adeniji

Adegoke Adeniji

South University - Savannah / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 1648522
person_outline Adegoke Adeniji's MOST POPULAR ARTICLES
1-) AKR1C3 as a target in castrate resistant prostate cancerAO Adeniji, M Chen, TM PenningThe Journal of steroid biochemistry and molecular biology 137, 136-149, 20131282013
2-) Development of Potent and Selective Inhibitors of Aldo–Keto Reductase 1C3 (Type 5 17β-Hydroxysteroid Dehydrogenase) Based on N-Phenyl-Aminobenzoates …AO Adeniji, BM Twenter, MC Byrns, Y Jin, M Chen, JD Winkler, ...Journal of medicinal chemistry 55 (5), 2311-2323, 2012992012
3-) Development of potent and selective indomethacin analogues for the inhibition of AKR1C3 (type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase) in castrate-resistant …AJ Liedtke, AO Adeniji, M Chen, MC Byrns, Y Jin, DW Christianson, ...Journal of medicinal chemistry 56 (6), 2429-2446, 2013892013
4-) Discovery of substituted 3-(phenylamino) benzoic acids as potent and selective inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3)AO Adeniji, BM Twenter, MC Byrns, Y Jin, JD Winkler, TM PenningBioorganic & medicinal chemistry letters 21 (5), 1464-1468, 2011632011
5-) Crystal structures of AKR1C3 containing an N-(aryl) amino-benzoate inhibitor and a bifunctional AKR1C3 inhibitor and androgen receptor antagonist. Therapeutic leads for …M Chen, AO Adeniji, BM Twenter, JD Winkler, DW Christianson, ...Bioorganic & medicinal chemistry letters 22 (10), 3492-3497, 2012602012